Literature DB >> 31618067

LncRNA SOX2OT Mediates Mitochondrial Dysfunction in Septic Cardiomyopathy.

Mengfei Chen1, Yan Guan1, Ao Li2, Ying-Zhu Zhao3, Ling Zhang1, Liang Zhang1, Yanxuan Gong4,5,6.   

Abstract

Researches establish an indispensable role of mitochondrial dysfunction in septic cardiomyopathy. We aimed to investigate the effects of long noncoding RNA (LncRNA) SOX2 overlapping transcript (SOX2OT) on mitochondrial dysfunction in septic cardiomyopathy. We observed an obvious overexpression of SOX2OT in septic hearts and cardiomyocytes. Knockdown of SOX2OT in mice recovered the reduced cardiac function, and improved the mitochondrial membrane potential impaired by lipopolysaccharide (LPS). SOX2OT overexpressed mice showed the opposite situation. In parallel, knockdown of SOX2OT in cardiomyocytes restored the mitochondrial membrane potential, along with reduced mitochondrial reactive oxygen species production induced by LPS, while overexpression of SOX2OT reversed these effects. Mechanistically, SOX2OT could regulate mitochondrial dysfunction in septic cardiomyopathy via SOX2. In general, SOX2OT contributed to mitochondrial dysfunction progression via inhibiting SOX2 expression in septic cardiomyopathy, which may provide a new insight for treatment of septic cardiomyopathy.

Entities:  

Keywords:  SOX2; SOX2OT; mitochondrial dysfunction; septic cardiomyopathy

Mesh:

Substances:

Year:  2019        PMID: 31618067     DOI: 10.1089/dna.2019.4839

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  10 in total

Review 1.  Long Noncoding RNA: Regulatory Mechanisms and Therapeutic Potential in Sepsis.

Authors:  Wei Wang; Ni Yang; Ri Wen; Chun-Feng Liu; Tie-Ning Zhang
Journal:  Front Cell Infect Microbiol       Date:  2021-05-12       Impact factor: 5.293

2.  LncRNA SOX2OT rs9839776 Polymorphism Reduces Sepsis Susceptibility in Southern Chinese Children.

Authors:  Zhiyuan Wu; Yongqin Yu; Lanyan Fu; Hanran Mai; Li Huang; Di Che; Jianping Tao; Xiaoqiong Gu
Journal:  J Inflamm Res       Date:  2020-12-10

Review 3.  Long Noncoding RNA SOX2-OT: Regulations, Functions, and Roles on Mental Illnesses, Cancers, and Diabetic Complications.

Authors:  Pu-Yu Li; Ping Wang; She-Gan Gao; Dao-Yin Dong
Journal:  Biomed Res Int       Date:  2020-11-26       Impact factor: 3.411

Review 4.  Long Non-Coding RNAs as Biomarkers and Therapeutic Targets in Sepsis.

Authors:  Chuqiao Wang; Guorui Liang; Jieni Shen; Haifan Kong; Donghong Wu; Jinxiang Huang; Xuefeng Li
Journal:  Front Immunol       Date:  2021-09-22       Impact factor: 7.561

Review 5.  Roles of LncRNAs in Regulating Mitochondrial Dysfunction in Septic Cardiomyopathy.

Authors:  Shuang Liu; Wei Chong
Journal:  Front Immunol       Date:  2021-11-24       Impact factor: 7.561

6.  Long non-coding RNA Sox2OT promotes coronary microembolization-induced myocardial injury by mediating pyroptosis.

Authors:  Liying Xuan; Danni Fu; Dong Zhen; Dongsong Bai; Lijun Yu; Guohua Gong
Journal:  ESC Heart Fail       Date:  2022-03-18

Review 7.  Current Status of Septic Cardiomyopathy: Basic Science and Clinical Progress.

Authors:  Huan Lin; Wenting Wang; Madeline Lee; Qinghe Meng; Hongsheng Ren
Journal:  Front Pharmacol       Date:  2020-03-03       Impact factor: 5.810

Review 8.  The Role of Long Non-coding RNAs in Sepsis-Induced Cardiac Dysfunction.

Authors:  Jiawen Li; Yulin Zhang; Donghui Zhang; Yifei Li
Journal:  Front Cardiovasc Med       Date:  2021-05-10

9.  Neferine Ameliorates Sepsis-Induced Myocardial Dysfunction Through Anti-Apoptotic and Antioxidative Effects by Regulating the PI3K/AKT/mTOR Signaling Pathway.

Authors:  Zhen Qi; Renrong Wang; Rongheng Liao; Song Xue; Yongyi Wang
Journal:  Front Pharmacol       Date:  2021-07-22       Impact factor: 5.988

Review 10.  Regulatory Role of Non-Coding RNAs on Immune Responses During Sepsis.

Authors:  Soudeh Ghafouri-Fard; Tayyebeh Khoshbakht; Bashdar Mahmud Hussen; Mohammad Taheri; Normohammad Arefian
Journal:  Front Immunol       Date:  2021-12-09       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.